Role of magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram in diagnosis of sporadic Creutzfeldt-Jakob disease
- PMID: 22968768
- PMCID: PMC3651672
- DOI: 10.1007/s00415-012-6664-6
Role of magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram in diagnosis of sporadic Creutzfeldt-Jakob disease
Abstract
Sporadic Creutzfeldt-Jakob disease (sCJD) is a rapidly progressive dementia (RPD) that can be difficult to identify antemortem, with definitive diagnosis requiring tissue confirmation. We describe the clinical, magnetic resonance imaging (MRI), cerebrospinal fluid (CSF), and electroencephalogram (EEG) measures of a small cohort of 30 patients evaluated for RPD. Clinical and diagnostic measures were cross-sectionally obtained from 17 sCJD patients (15 definite, two probable), 13 non-prion rapidly progressive dementia patients (npRPD), and 18 unimpaired controls. In a subset of patients (nine sCJD and nine npRPD) diffusion tensor imaging (DTI) measures [fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD)] were also obtained for the caudate, corpus callosum, posterior limb of the internal capsule, pulvinar, precuneus, and frontal lobe. Differences among groups were assessed by an analysis of variance. Compared to npRPD individuals, sCJD patients had cerebellar dysfunction, significantly higher CSF tau, "positive" CSF 14-3-3, and hyperintensities on diffusion-weighted imaging (DWI) that met previously established imaging criteria for sCJD. EEG changes were similar for the two groups. In addition, sCJD patients had significant decreases in DTI measures (MD, AD, RD but not FA) within the caudate and pulvinar compared to either npRPD patients or unimpaired controls. Our results confirm that CSF abnormalities and MRI (especially DWI) can assist in distinguishing sCJD patients from npRPD patients. Future longitudinal studies using multiple measures (including CSF and MRI) are needed for evaluating pathological changes seen in sCJD patients.
Figures



Similar articles
-
Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias.Neurology. 2011 May 17;76(20):1711-9. doi: 10.1212/WNL.0b013e31821a4439. Epub 2011 Apr 6. Neurology. 2011. PMID: 21471469 Free PMC article.
-
Clinical overlap between Jakob-Creutzfeldt disease and Lewy body disease.Can J Neurol Sci. 2012 May;39(3):304-10. doi: 10.1017/s0317167100013421. Can J Neurol Sci. 2012. PMID: 22547509 Free PMC article.
-
Evolution of Diffusion-Weighted Magnetic Resonance Imaging Signal Abnormality in Sporadic Creutzfeldt-Jakob Disease, With Histopathological Correlation.JAMA Neurol. 2016 Jan;73(1):76-84. doi: 10.1001/jamaneurol.2015.3159. JAMA Neurol. 2016. PMID: 26569479 Free PMC article. Clinical Trial.
-
Clinical findings and diagnostic tests in Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease.Folia Neuropathol. 2004;42 Suppl B:24-38. Folia Neuropathol. 2004. PMID: 16903140 Review.
-
Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease.Neurology. 2005 Feb 22;64(4):643-8. doi: 10.1212/01.WNL.0000151847.57956.FA. Neurology. 2005. PMID: 15728285 Review.
Cited by
-
Magnetic resonance imaging findings in probable Creutzfeld-Jacob disease: comparison with electroencephalography and cerebrospinal fluid characteristics.Acta Radiol Short Rep. 2014 Nov 14;3(10):2047981614552218. doi: 10.1177/2047981614552218. eCollection 2014 Nov. Acta Radiol Short Rep. 2014. PMID: 25535567 Free PMC article.
-
Evaluation of a New Criterion for Detecting Prion Disease With Diffusion Magnetic Resonance Imaging.JAMA Neurol. 2020 Sep 1;77(9):1141-1149. doi: 10.1001/jamaneurol.2020.1319. JAMA Neurol. 2020. PMID: 32478816 Free PMC article.
-
White Matter Integrity Involvement in the Preclinical Stage of Familial Creutzfeldt-Jakob Disease: A Diffusion Tensor Imaging Study.Front Aging Neurosci. 2021 May 19;13:655667. doi: 10.3389/fnagi.2021.655667. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34093166 Free PMC article.
-
Sleep Pathology in Creutzfeldt-Jakob Disease.J Clin Sleep Med. 2016 Jul 15;12(7):1033-9. doi: 10.5664/jcsm.5944. J Clin Sleep Med. 2016. PMID: 27250807 Free PMC article.
-
Application of quantitative DTI metrics in sporadic CJD.Neuroimage Clin. 2014 Jan 31;4:426-35. doi: 10.1016/j.nicl.2014.01.011. eCollection 2014. Neuroimage Clin. 2014. PMID: 24624328 Free PMC article.
References
-
- Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999;46(2):224–233. - PubMed
-
- Kovacs GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, van Duijn C, Collins SJ, Boyd A, Giulivi A, Coulthart M, Delasnerie-Laupretre N, Brandel JP, Zerr I, Kretzschmar HA, de Pedro-Cuesta J, Calero-Lara M, Glatzel M, Aguzzi A, Bishop M, Knight R, Belay G, Will R, Mitrova E. Genetic prion disease: the EUROCJD experience. Human genetics. 2005;118(2):166–174. - PubMed
-
- World OH. Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation. September 1, 2010 1998
-
- Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A, Pocchiari M, Almonti S, Cuadrado-Corrales N, de Pedro-Cuesta J, Budka H, Gelpi E, Glatzel M, Tolnay M, Hewer E, Zerr I, Heinemann U, Kretszchmar HA, Jansen GH, Olsen E, Mitrova E, Alperovitch A, Brandel JP, Mackenzie J, Murray K, Will RG. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain. 2006;129(Pt 9):2278–2287. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous